Multicentre randomized-controlled clinical trial of Ipocol, a new enteric-coated form of mesalazine, in comparison with Asacol in the treatment of ulcerative colitis

Forbes, A ORCID: https://orcid.org/0000-0001-7416-9843, Al-Damluji, A, Ashworth, S, Bramble, M, Herbert, K, Ho, J, Kang, J-Y, Przemioslo, R and Shetty, A (2005) Multicentre randomized-controlled clinical trial of Ipocol, a new enteric-coated form of mesalazine, in comparison with Asacol in the treatment of ulcerative colitis. Alimentary Pharmacology and Therapeutics, 21 (9). pp. 1099-1104. ISSN 0269-2813

Full text not available from this repository. (Request a copy)

Abstract

5-Aminosalicylates remain important in the treatment of ulcerative colitis, but it is uncertain if the various preparations currently available are equivalent given the different delivery systems that exist. Generic prescription of mesalazine (mesalamine) is therefore inappropriate. Ipocol has recently become available as an alternative to Asacol-MR.

Item Type:	Article
Uncontrolled Keywords:	anti-inflammatory agents, non-steroidal,colitis, ulcerative,female,humans,male,mesalamine,middle aged,tablets, enteric-coated,treatment outcome
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Gastroenterology and Gut Biology Faculty of Medicine and Health Sciences > Research Groups > Nutrition and Preventive Medicine
Depositing User:	Pure Connector
Date Deposited:	06 Aug 2014 10:44
Last Modified:	20 Oct 2022 23:59
URI:	https://ueaeprints.uea.ac.uk/id/eprint/49633
DOI:	10.1111/j.1365-2036.2005.02442.x

Actions (login required)

View Item